Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

The PML domain of PML-RARα blocks senescence to promote leukemia.

Korf K, Wodrich H, Haschke A, Ocampo C, Harder L, Gieseke F, Pollmann A, Dierck K, Prall S, Staege H, Ma H, Horstmann MA, Evans RM, Sternsdorf T.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12133-8. doi: 10.1073/pnas.1412944111. Epub 2014 Aug 4.

2.

Transcriptional activation of the adenoviral genome is mediated by capsid protein VI.

Schreiner S, Martinez R, Groitl P, Rayne F, Vaillant R, Wimmer P, Bossis G, Sternsdorf T, Marcinowski L, Ruzsics Z, Dobner T, Wodrich H.

PLoS Pathog. 2012 Feb;8(2):e1002549. doi: 10.1371/journal.ppat.1002549. Epub 2012 Feb 23.

3.
4.

Forced retinoic acid receptor alpha homodimers prime mice for APL-like leukemia.

Sternsdorf T, Phan VT, Maunakea ML, Ocampo CB, Sohal J, Silletto A, Galimi F, Le Beau MM, Evans RM, Kogan SC.

Cancer Cell. 2006 Feb;9(2):81-94.

5.

Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications.

Zhao X, Sternsdorf T, Bolger TA, Evans RM, Yao TP.

Mol Cell Biol. 2005 Oct;25(19):8456-64.

6.

Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.

Janka C, Selmi C, Gershwin ME, Will H, Sternsdorf T.

Hepatology. 2005 Mar;41(3):609-16.

PMID:
15726652
7.

Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.

Asper M, Sternsdorf T, Hass M, Drosten C, Rhode A, Schmitz H, Günther S.

J Virol. 2004 Mar;78(6):3162-9.

8.

SUMO.

Sternsdorf T, Jensen K, Freemont PS.

Curr Biol. 2003 Apr 1;13(7):R258-9. No abstract available.

9.

Transcriptional regulation in acute promyelocytic leukemia.

Lin RJ, Sternsdorf T, Tini M, Evans RM.

Oncogene. 2001 Oct 29;20(49):7204-15. Review.

10.

Regulation of p53 activity in nuclear bodies by a specific PML isoform.

Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, Pandolfi PP, Will H, Schneider C, Del Sal G.

EMBO J. 2000 Nov 15;19(22):6185-95.

11.

The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein.

Pitkänen J, Doucas V, Sternsdorf T, Nakajima T, Aratani S, Jensen K, Will H, Vähämurto P, Ollila J, Vihinen M, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Krohn K, Peterson P.

J Biol Chem. 2000 Jun 2;275(22):16802-9.

12.

Cell cycle regulation of PML modification and ND10 composition.

Everett RD, Lomonte P, Sternsdorf T, van Driel R, Orr A.

J Cell Sci. 1999 Dec;112 ( Pt 24):4581-8.

13.

A dynamic connection between centromeres and ND10 proteins.

Everett RD, Earnshaw WC, Pluta AF, Sternsdorf T, Ainsztein AM, Carmena M, Ruchaud S, Hsu WL, Orr A.

J Cell Sci. 1999 Oct;112 ( Pt 20):3443-54.

14.

PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.

Sternsdorf T, Puccetti E, Jensen K, Hoelzer D, Will H, Ottmann OG, Ruthardt M.

Mol Cell Biol. 1999 Jul;19(7):5170-8.

16.

Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif.

Guldner HH, Szostecki C, Schröder P, Matschl U, Jensen K, Lüders C, Will H, Sternsdorf T.

J Cell Sci. 1999 Mar;112 ( Pt 5):733-47.

17.
18.

Nuclear dots: actors on many stages.

Sternsdorf T, Grötzinger T, Jensen K, Will H.

Immunobiology. 1997 Dec;198(1-3):307-31. Review.

PMID:
9442402
19.
20.

Cellular localization, expression, and structure of the nuclear dot protein 52.

Sternsdorf T, Jensen K, Züchner D, Will H.

J Cell Biol. 1997 Jul 28;138(2):435-48.

Supplemental Content

Loading ...
Support Center